1-8 of 8
Kasper Rossing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors

Gudbjörg Andrésdóttir, Majken L. Jensen, Bendix Carstensen, Hans-Henrik Parving, Kasper Rossing, Tine W. Hansen, Peter Rossing
Journal: Diabetes Care
Diabetes Care 2014;37(6):1660–1667
https://doi.org/10.2337/dc13-2036
Published: 10 May 2014
View article titled, Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
Open the PDF for Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors in another window
Includes: Supplementary data
Journal Articles

Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy

Peter Rossing, DMSC, Kasper Rossing, MD, Peter Gæde, MD, Oluf Pedersen, DMSC, Hans-Henrik Parving, DMSC
Journal: Diabetes Care
Diabetes Care 2006;29(5):1024–1030
https://doi.org/10.2337/dc05-2201
Published: 01 May 2006
View article titled, Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy
Open the PDF for Monitoring Kidney Function in Type 2 Diabetic Patients With Incipient and Overt Diabetic Nephropathy in another window
Journal Articles

Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : A randomized, double-masked, cross-over study

Kasper Rossing, MD, Katrine J. Schjoedt, MD, Ulla M. Smidt, Frans Boomsma, PHD, Hans-Henrik Parving, MD, DMSC
Journal: Diabetes Care
Diabetes Care 2005;28(9):2106–2112
https://doi.org/10.2337/diacare.28.9.2106
Published: 01 September 2005
View article titled, Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : <subtitle>A randomized, double-masked, cross-over study</subtitle>
Open the PDF for Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy : <subtitle>A randomized, double-masked, cross-over study</subtitle> in another window
Journal Articles

Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy: A randomized double-blind crossover trial

Kasper Rossing, MD, Peter Jacobsen, MD, Lotte Pietraszek, Hans-Henrik Parving, DMSC, MD
Journal: Diabetes Care
Diabetes Care 2003;26(8):2268–2274
https://doi.org/10.2337/diacare.26.8.2268
Published: 01 August 2003
View article titled, Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy: <subtitle>A randomized double-blind crossover trial</subtitle>
Open the PDF for Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy: <subtitle>A randomized double-blind crossover trial</subtitle> in another window
Journal Articles

Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes

Peter Hovind, MD, Lise Tarnow, DMSC, MD, Kasper Rossing, MD, Peter Rossing, DMSC, MD, Stefanie Eising, MD, Nicolai Larsen, MD, PHD, Christian Binder, DMSC, MD, Hans-Henrik Parving, DMSC, MD
Journal: Diabetes Care
Diabetes Care 2003;26(4):1258–1264
https://doi.org/10.2337/diacare.26.4.1258
Published: 01 April 2003
View article titled, Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Open the PDF for Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes in another window
Journal Articles

Comparative Effects of Irbesartan on Ambulatory and Office Blood Pressure: A substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study

Kasper Rossing, MD, Per K. Christensen, MD, Steen Andersen, MD, Peter Hovind, MD, Henrik Post Hansen, MD, Hans-Henrik Parving, PROF, DMSC, MD
Journal: Diabetes Care
Diabetes Care 2003;26(3):569–574
https://doi.org/10.2337/diacare.26.3.569
Published: 01 March 2003
View article titled, Comparative Effects of Irbesartan on Ambulatory and Office Blood Pressure: <subtitle>A substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study</subtitle>
Open the PDF for Comparative Effects of Irbesartan on Ambulatory and Office Blood Pressure: <subtitle>A substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study</subtitle> in another window
Journal Articles

Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy: A double-blind randomized cross-over study

Kasper Rossing, MD, Per K. Christensen, MD, Birgitte V. Hansen, Bendix Carstensen, Hans-Henrik Parving, Prof., DMSC, MD
Journal: Diabetes Care
Diabetes Care 2003;26(1):150–155
https://doi.org/10.2337/diacare.26.1.150
Published: 01 January 2003
View article titled, Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy: <subtitle>A double-blind randomized cross-over study</subtitle>
Open the PDF for Optimal Dose of Candesartan for Renoprotection in Type 2 Diabetic Patients With Nephropathy: <subtitle>A double-blind randomized cross-over study</subtitle> in another window
Journal Articles

Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy: A randomized double-blind crossover study

Kasper Rossing, MD, Per K. Christensen, MD, Berit R. Jensen, Hans-Henrik Parving, Prof., MD, DMSC
Journal: Diabetes Care
Diabetes Care 2002;25(1):95–100
https://doi.org/10.2337/diacare.25.1.95
Published: 01 January 2002
View article titled, Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy: <subtitle>A randomized double-blind crossover study </subtitle>
Open the PDF for Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy: <subtitle>A randomized double-blind crossover study </subtitle> in another window